EXETF (Extendicare) Moat Score: 3/10 (As of Jun. 26, 2026)


EXETF Extendicare Inc EXETF
76 GF Score
Price $24.85
GF Value $10.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Extendicare Moat Score?

Extendicare EXETF +0.49% 76 Moat Score is 3 as of Jun. 26, 2026. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $10.03 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Extendicare ranks better than 84.29% on this metric.

Extendicare has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Extendicare has No Moat: Extendicare Inc operates in a competitive healthcare market with minimal differentiation. It lacks significant regulatory barriers, strong brand strength, or durable cost advantages, resulting in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Extendicare might have No Moat - Very weak/transient advantages.

Extendicare  (OTCPK:EXETF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Extendicare Moat Score Related Terms

EXETF vs HCA, THC, DVA: Moat Score Comparison

For the Medical Care Facilities subindustry, Extendicare's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Extendicare Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's Moat Score distribution charts can be found below:

* The bar in red indicates where Extendicare's Moat Score falls into.


EXETF
76GF Score
Extendicare Inc EXETF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Extendicare (EXETF) has a Moat Score of 3 as of Jun. 26, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Extendicare ranks #107 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 15.7%.
Is Extendicare's Moat Score too high?
Extendicare's current Moat Score is 3. Based on the distribution chart, Extendicare ranks #107 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Moat Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #107 out of 681 companies for Moat Score. This places Extendicare in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Extendicare's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.03, compared to a current price of $24.85 — trading 147.8% above its estimated fair value. The current Moat Score is 3. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Extendicare (EXETF), the current Moat Score is 3 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Extendicare (EXETF) Overvalued in 2026?

Based on GuruFocus' analysis, Extendicare stock appears to be overvalued. The current stock price of $24.85 is trading 147.8% above its estimated GF Value™ of $10.03. GuruFocus considers Extendicare to be Significantly Overvalued.

Key valuation signals for EXETF:

  • Moat Score: 3
  • GF Value™: $10.03 vs. price of $24.85 (147.8% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Extendicare Business Description

Address 3000 Steeles Avenue East, Suite 400, Markham, ON, CAN, L3R 4T9
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score

Get the complete analysis for EXETF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.85
Price
$10.03
GF Value